BioWorld

Sep. 1, 2003

View Archived Issues

Holiday Notice

Underwriters' Performance On All Public Offerings Jan. 1 - Aug. 20, 2003: Full Credit To All Underwriters, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings Jan. 1 - Aug. 20, 2003: Full Credit To All Underwriters, Ranked By After-Market Performance*#

Underwriters' Performance On All Public Offerings From Jan. 1 - Aug. 20, 2003: Full Credit To Lead Underwriter, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings From Jan. 1 - Aug. 20, 2003: Full Credit To Lead Underwriter, Ranked By After-Market Performance#

Stock Winners and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Signs Suggest Open IPO Window: Time Is Right' For Biotech Sector

Just when "IPO" had begun to sound like a code acronym or something from a foreign language, biotechnology's long drought with regard to initial public offerings seems to have ended with an August downpour. Read More

Money Raised Year To Date

Today's news in brief

BioWorld

BioWorld briefs for Jan 20, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 20, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...